The arterial network was informed for the first time that on January 2, 2019, Jingzhi Medical, a provider of precision intelligent “navigation + robot†surgical system, announced the completion of the 10,000-per-pre-A round of financing, the investor is Sanze Capital.
It is reported that the funds will be mainly used for multi-center clinical trials of two fist products and upgrade research and development of surgical treatment robot projects. Mr. Gu Lijun, founder of Jingwei Medical, told Artex. The company is conducting clinical trials in conjunction with several well-known hospitals in Beijing and Shanghai.
Jingwei Medical is a medical high-tech company dedicated to the development and production of navigation and robot systems for precision surgery. Founded in May 2016, it is headquartered in Shanghai, China, and has invested in a production base with a total area of ​​1,300 square meters in Nantong, Jiangsu. . At present, Jingwei Medical focuses on the development and production of low-cost and high-precision interventional navigation systems and surgical robots.
So far, Jingyu Medical has completed two rounds of financing. The last round was the Angel Wheel financing from Lenovo Star in 2016. Mr. Gu Lijun said that Jingwei Medical was very fortunate to be recognized by Lenovo Star in the Angel Wheel, and was helped by Lenovo Star in the company's operation and the second round of financing. “In the Pre-A round, we are fortunate to have the support of Sanze Capital. Sanze Capital has a very professional medical investment and post-investment team that will help to improve the follow-up of medical care.â€
Mr. Zeng Wenbing, senior partner of Sanze Capital, said: "With the support of national policies in recent years, the return of high-end talents at home and abroad has emerged as a high-end medical device technology enterprise that is close to or reaches the international leading level. Tumor is the first in today's society. A killer, early detection and early treatment of tumors is an industry trend, especially in the field of lung cancer and liver. The market is in urgent need of advanced technology to improve the diagnosis and treatment and reduce the burden on patients. We are optimistic about the long-term development of this field. Potential, optimistic about the combination of excellent research team and excellent business leaders, and willing to give full play to our investment experience in the medical industry for many years to support the development of the team."
Let medical imaging go from radiology to operating room
Due to strong pertinence, small secondary damage and good prognosis, minimally invasive surgery has become the mainstream trend of surgical clinical treatment. Under non-open surgery conditions, the human body is like a black box, the doctor can not determine the lesions in the body, locate the lesions. With the rapid development of medical imaging technology, CT, nuclear magnetic resonance, ultrasound and other imaging methods provide the necessary images for clinical diagnosis and treatment.
However, the current mainstream application of medical imaging is still in the diagnostic segment, and surgical treatment rarely benefits from medical imaging. In fact, for complex minimally invasive surgery, especially in various innovative tumor treatment methods that have emerged in recent years, precise positioning and navigation in image-guided surgery is essential to ensure the quality of surgery.
Jingwei Medical Co., Ltd. attempts to integrate multi-disciplinary techniques such as medical imaging, clinical minimally invasive, virtual reality, visual positioning, and robotics. It applies preoperative intraoperative medical image fusion to the operation, adopts the latest visual positioning principle, and integrates advanced optics and electromagnetics. The spatial positioning technology realizes the precise positioning of intraoperative instruments and human tissues, and creates virtual reality surgical scenes for doctors to improve the intuitiveness, precision and efficiency of minimally invasive surgery.
"We make full use of the development of the latest technology to get medical images out of the radiology department and enter the operating room." Mr. Gu Lijun said that Jingjing Medical has entered the field of clinical treatment such as early tumor screening, lesion interventional resection and hot and cold ablation.
At present, the first product to be put into clinical trials is the interventional surgery navigation system, which is mainly used for lung and other thoracic and abdominal tumor puncture.
As we all know, lung cancer has become the first killer of human health. Early diagnosis and early treatment are the key to improving the cure rate of lung cancer at this stage. The use of a puncture needle to intervene in the lung tissue for biopsy remains the clinical gold standard for the diagnosis of lung tumors.
However, convenient imaging techniques such as ultrasound are not applicable in the lungs. The lesions in the early stage of lung cancer are very small (eg, less than 10 mm). Traditional CT and C-arm guided procedures are difficult and time-consuming. Under the current technical conditions, doctors can only take or continue to observe, miss the early best treatment period; or excessive resection of the benign, resulting in unnecessary damage.
One of the foreign solutions is to use the bronchial magnetic navigation technique to achieve the location of lesions in early pulmonary nodules. However, this solution seems to solve the most difficult positioning problem, but it is complicated and expensive. In addition, because the bronchoscope interferes with the magnetic field distribution, the accuracy of the navigation system is limited.
With the improved magnetic navigation technology of CT, the CT is used as the image source, and only 2-3 CT scans are needed (which will be further reduced to 1 time). The X-ray exposure dose is small, but it can accurately locate a few millimeters. Nodules, easy to operate, low cost.
According to clinical statistics, the use of fine medical magnetic navigation technology to guide surgery, the length of surgery will be greatly shortened, the number of needles and total radiation can be greatly improved.
According to Mr. Gu Lijun, Jingjing Medical Interventional Surgery Navigation System and Intelligent Navigation Puncture Needle have completed all R&D and type registration tests, and developed a complete clinical trial program to conduct clinical trials in several top hospitals in China. “We attach great importance to clinical trials of products, select the best clinical hospitals, and do the most standardized clinical programs, strictly in accordance with the standards of international medical companies.â€
Providing a precise technology platform for innovative cancer treatment solutions
In recent years, research and development of innovative tumor treatment programs are on the rise, with hot and cold ablation, nanoknife, particles and gene therapy becoming popular tracks. Jingwei Medical is positioned to provide intelligent and precise surgical diagnosis and treatment systems for various new types of cancer treatment programs, to help these treatments reach the lesions accurately, quickly, safely and effectively.
The reason why we chose to start from the relatively low-temperature technology of precision surgery platform is that Mr. Gu Lijun’s answer is that many effective innovative tumor treatment solutions are difficult to reach due to the inability to accurately reach the target area in the body. Through the platform technology from the in vitro to the precise path of the lesion, Jingrui Medical provides this platform technology through image guidance. "Surgery is like a battle with a lesion, the treatment is a bullet, and the fine medical solution. The role is to provide accurate weapons."
In addition to the interventional surgical navigation system and intelligent navigation puncture needles, Jingke Medical's oncology precision puncture robot system has also completed the first generation of prototype development, and will realize intelligent puncture guidance of tumors in the future.
In addition, Jingwei Medical has a number of backup research projects, including a more complex multi-disciplinary surgical robotic system and several minimally invasive diagnostic systems around the tumor and cardiovascular.
Mr. Gu Lijun told the Arterial Network that the vision of Jingwei Medical is to become a solution provider for intelligent surgery in the whole department. In the future, artificial intelligence technology will be introduced to enable interventional surgery.
On the team side, Jingwei Medical brings together the best research teams and the best business leaders in the field. The three founders of Jingwei Medical are senior serial entrepreneurs in the medical device industry. Mr. Gu Lijun has served as an associate researcher at the Medical Imaging Laboratory of the Roberts Medical Research Institute in Canada. He has been responsible for the technical transformation of surgical navigation research results and is also the technical director of CEDARA.
In addition, Mr. Gu Lijun also cooperated with Harvard Medical School in the United States to conduct international research on surgical navigation projects.
Previously, Mr. Gu Lijun founded Suzhou Decair Medical Technology Co., Ltd. The other two founders have nearly 20 years of senior industry experience, with experienced management leadership experience, rich marketing experience and medical technology incubation experience. The entire team's capabilities are cross-complementary.
According to Mr. Gu Lijun, Jingjing Medical plans to launch the next round of tens of millions of A-round financing in the summer of 2019. The funds are mainly used for market development and clinical trials and registration of the second and third products.
Instant tea refers to a class of tea products that are solid, water-soluble, and still retain the original tea flavor after dilution, using traditional tea leaves as raw materials and processed through extraction, clarification, concentration, inversion, drying and other processes.
Instant Powder,Instant Green Tea Powder,Black Tea Instant Powder,Jasmine Tea Powder,Rose Flavoured Tea Powder
Shaanxi HuiKe Botanical Development Co.,Ltd , https://www.oasis-hk.com